Related Experiment Video
Updated: Nov 28, 2025

Study of Experimental Organ Donation Models for Lung Transplantation
Published on: March 15, 2024
Challenges in Brain Death Determination and Apnea Testing for Patients with COVID-19
Yazan Radaideh1, Rajeev Garg1, Amina A Abdalla2
1Department of Neurological Sciences, Section of Neurocritical Care, Rush University Medical Center, Chicago, IL, United States.
A novel apnea testing method using a T-piece and HME filter safely determined brain death in a COVID-19 positive patient. This technique minimizes healthcare worker exposure to SARS-CoV-2 during critical brain death evaluations.
Area of Science:
- Neurology
- Critical Care Medicine
- Infectious Disease
Background:
- Apnea testing is crucial for brain death determination.
- Patients with SARS-CoV-2 pose aerosolization risks during standard apnea tests.
- Protecting healthcare workers from COVID-19 exposure is paramount.
Related Concept Videos
Acute Respiratory Failure-IV
Cardiopulmonary Resuscitation II: ACLS Airway Management
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration...
Sleep Apnea
The condition is more prevalent among...
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Respiratory Volumes and Capacities I

